scholarly journals HIV-1 Genotypic Resistance Patterns Predict Response to saquinavir–ritonavir Therapy in Patients in Whom Previous Protease Inhibitor Therapy Had Failed

1999 ◽  
Vol 131 (11) ◽  
pp. 813 ◽  
Author(s):  
Andrew R. Zolopa ◽  
Robert W. Shafer ◽  
Ann Warford ◽  
Jose G. Montoya ◽  
Phillip Hsu ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Inhibitor Therapy ◽  
Protease Inhibitor Therapy ◽  
Genotypic Resistance ◽  
Resistance Patterns ◽  
Hiv 1

Occurrence of Selective Ritonavir Nonadherence and Dose-Staggering in Recipients of Boosted HIV-1 Protease Inhibitor Therapy

2009 ◽  
Vol 10 (3) ◽  
pp. 135-142 ◽  
Author(s):  
Jonathan Shuter ◽  
Julie A. Sarlo ◽  
Richard A. Rode ◽  
Barry S. Zingman
Keyword(s):  
Protease Inhibitor ◽  
Inhibitor Therapy ◽  
Protease Inhibitor Therapy ◽  
Hiv 1

scholarly journals Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy

1998 ◽  
Vol 95 (24) ◽  
pp. 14441-14446 ◽  
Author(s):  
M. Nijhuis ◽  
C. A. B. Boucher ◽  
P. Schipper ◽  
T. Leitner ◽  
R. Schuurman ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Stochastic Processes ◽  
Inhibitor Therapy ◽  
Protease Inhibitor Therapy ◽  
Hiv 1

Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapy

2012 ◽  
Vol 202 (2) ◽  
pp. 117-124 ◽  
Author(s):  
Christoph Stephan ◽  
Valentin Bartha ◽  
Eva Herrmann ◽  
Nils von Hentig ◽  
Pavel Khaykin ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Inhibitor Therapy ◽  
Protease Inhibitor Therapy ◽  
Hiv 1

The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir

AIDS ◽  
1998 ◽  
Vol 12 (5) ◽  
pp. F9-F14 ◽  
Author(s):  
Dale J. Kempf ◽  
Richard A. Rode ◽  
Yi Xu ◽  
Eugene Sun ◽  
Margo E. Heath-Chiozzi ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Viral Suppression ◽  
Inhibitor Therapy ◽  
Protease Inhibitor Therapy ◽  
Hiv 1

Mutation rate in hepatitis C virus NS3 protease is not influenced by HIV-1 protease inhibitor therapy

AIDS ◽  
2008 ◽  
Vol 22 (13) ◽  
pp. 1694-1696 ◽  
Author(s):  
Philippe Halfon ◽  
Marc Bourlière ◽  
Hacène Khiri ◽  
Guillaume Pénaranda ◽  
Agnes Martineau ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Protease Inhibitor ◽  
Mutation Rate ◽  
Inhibitor Therapy ◽  
Protease Inhibitor Therapy ◽  
Ns3 Protease ◽  
Hiv 1

HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy

2016 ◽  
Vol 205 (6) ◽  
pp. 575-583 ◽  
Author(s):  
Maximilian Donath ◽  
◽  
Timo Wolf ◽  
Martin Stürmer ◽  
Eva Herrmann ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Protease Inhibitor ◽  
Inhibitor Therapy ◽  
Protease Inhibitor Therapy ◽  
Hiv 1 ◽  
Over Time

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease

The Lancet ◽  
1998 ◽  
Vol 351 (9098) ◽  
pp. 252-255 ◽  
Author(s):  
Elizabeth M Race ◽  
Jennifer Adelson-Mitty ◽  
Gila R Kriegel ◽  
Tamar F Barlam ◽  
Keith A Reimann ◽  
...  
Keyword(s):  
Protease Inhibitor ◽  
Inhibitor Therapy ◽  
Protease Inhibitor Therapy ◽  
Hiv 1
Sign in / Sign up

Export Citation Format

Share Document